Research Article
Prognostic and Diagnostic Significance of circRNA Expression in Esophageal Cancer: A Meta-analysis
Table 4
Clinical parameters of circRNAs in esophageal cancer.
| Parameters | Tumor promoter | Tumor suppressor | OR | 95% CI | | OR | 95% CI | |
| Age (old/young) | 1.096 | (0.701, 1.713) | 0.688 | 1.147 | (0.427, 3.083) | 0.786 | Gender (M/W) | 0.961 | (0.660, 1.399) | 0.835 | 1.201 | (0.369, 3.909) | 0.761 | Tumor size (large/small) | 1.68 | (1.031, 2.738) | 0.037 | 2.214 | (0.792, 6.190) | 0.13 | Differentiation grade | 1.02 | (0.673, 1.545) | 0.925 | 2.708 | (0.559, 13.115) | 0.216 | TNM stage (/) | 2.214 | (0.713, 6.876) | 0.169 | 2.891 | (1.052, 7.949) | 0.04 | T classification (/) | 1.729 | (1.074, 2.785) | 0.024 | — | — | — | Lymph node metastasis (Y/N) | 4.657 | (1.951, 11.112) | 0.001 | — | — | — | Distant metastasis (Y/N) | 8.47 | (0.594, 120.694) | 0.115 | — | — | — |
|
|
CI, confidence interval; M, men; N, no; W, women; Y, yes; OR, odds ratio; na, not available. The results are in bold if . |